Regenesis Orthobiologics Limited
12578145
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
30/12/2026
Confirmation statement
Last: 08/12/2025
Due 22/12/2026
Industry
Officers
director · Since 29/04/2020
DOCTOR
BRITISH · ENGLAND · Age 50
Also on 11 other boards
Persons with Significant Control
Dr Fahad Gulamdastagir Attar
British · England · Age 50
Suite 2 Parkway 5, Parkway Business Centre, Manchester, M14 7HR
Notified 29/04/2020
CompanyRankvs 1594+ SIC 47749 peers36
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
-£85k
Balance sheet strength
Cash
£631
Cash in the bank
Net Current Assets
-£85k
Working capital
Current Assets
£631
Current Liabilities
£85k
Debtors
£11k
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.01 | -£39k |
| 2024 | 0.20 | +£1k |
| 2023 | 0.11 | -£19k |
Derived from filed accounts. Not audited figures.